Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

comoR: a software for disease comorbidity risk assessment.

Moni MA, Liò P.

J Clin Bioinforma. 2014 May 23;4:8. doi: 10.1186/2043-9113-4-8. eCollection 2014.

PMID:
25045465
[PubMed]
Free PMC Article
2.

Decitabine reactivated pathways in platinum resistant ovarian cancer.

Fang F, Zuo Q, Pilrose J, Wang Y, Shen C, Li M, Wulfridge P, Matei D, Nephew KP.

Oncotarget. 2014 Jun 15;5(11):3579-89.

PMID:
25003579
[PubMed - in process]
Free PMC Article
3.

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.

Candido S, Maestro R, Polesel J, Catania A, Maira F, Signorelli SS, McCubrey JA, Libra M.

Oncotarget. 2014 Mar 30;5(6):1576-94.

PMID:
24742531
[PubMed - in process]
Free PMC Article
4.

Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.

Walentowicz P, Krintus M, Sadlecki P, Grabiec M, Mankowska-Cyl A, Sokup A, Walentowicz-Sadlecka M.

PLoS One. 2014 Mar 5;9(3):e90575. doi: 10.1371/journal.pone.0090575. eCollection 2014.

PMID:
24599287
[PubMed - in process]
Free PMC Article
5.

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers.

Li H, Chiappinelli KB, Guzzetta AA, Easwaran H, Yen RW, Vatapalli R, Topper MJ, Luo J, Connolly RM, Azad NS, Stearns V, Pardoll DM, Davidson N, Jones PA, Slamon DJ, Baylin SB, Zahnow CA, Ahuja N.

Oncotarget. 2014 Feb 15;5(3):587-98.

PMID:
24583822
[PubMed - in process]
Free PMC Article
6.

Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancer.

Kim Y, Guntupalli SR, Lee SJ, Behbakht K, Theodorescu D, Lee JK, Diamond JR.

PLoS One. 2014 Feb 5;9(2):e86532. doi: 10.1371/journal.pone.0086532. eCollection 2014.

PMID:
24505259
[PubMed - in process]
Free PMC Article
7.

The chromatin remodeller CHD8 is required for E2F-dependent transcription activation of S-phase genes.

Subtil-Rodríguez A, Vázquez-Chávez E, Ceballos-Chávez M, Rodríguez-Paredes M, Martín-Subero JI, Esteller M, Reyes JC.

Nucleic Acids Res. 2014 Feb;42(4):2185-96. doi: 10.1093/nar/gkt1161. Epub 2013 Nov 21.

PMID:
24265227
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling.

Montero-Meléndez T, Llor X, García-Planella E, Perretti M, Suárez A.

PLoS One. 2013 Oct 14;8(10):e76235. doi: 10.1371/journal.pone.0076235. eCollection 2013.

PMID:
24155895
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Network-based stratification of tumor mutations.

Hofree M, Shen JP, Carter H, Gross A, Ideker T.

Nat Methods. 2013 Nov;10(11):1108-15. doi: 10.1038/nmeth.2651. Epub 2013 Sep 15.

PMID:
24037242
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Sample size requirements for training high-dimensional risk predictors.

Dobbin KK, Song X.

Biostatistics. 2013 Sep;14(4):639-52. doi: 10.1093/biostatistics/kxt022. Epub 2013 Jul 19.

PMID:
23873895
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Stromal responses among common carcinomas correlated with clinicopathologic features.

Chen JL, Espinosa I, Lin AY, Liao OY, van de Rijn M, West RB.

Clin Cancer Res. 2013 Sep 15;19(18):5127-35. doi: 10.1158/1078-0432.CCR-12-3127. Epub 2013 Jun 26.

PMID:
23804424
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.

Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R.

PLoS Comput Biol. 2013;9(3):e1002975. doi: 10.1371/journal.pcbi.1002975. Epub 2013 Mar 21.

PMID:
23555212
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome.

Ganzfried BF, Riester M, Haibe-Kains B, Risch T, Tyekucheva S, Jazic I, Wang XV, Ahmadifar M, Birrer MJ, Parmigiani G, Huttenhower C, Waldron L.

Database (Oxford). 2013 Apr 2;2013:bat013. doi: 10.1093/database/bat013. Print 2013.

PMID:
23550061
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker.

Rachidi SM, Qin T, Sun S, Zheng WJ, Li Z.

PLoS One. 2013;8(3):e57911. doi: 10.1371/journal.pone.0057911. Epub 2013 Mar 25.

PMID:
23536776
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identifying master regulators of cancer and their downstream targets by integrating genomic and epigenomic features.

Gevaert O, Plevritis S.

Pac Symp Biocomput. 2013:123-34.

PMID:
23424118
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, Zhao Y, Reynolds S, Cheng H, Rupaimoole R, Cogdell D, Nykter M, Broaddus R, Rodriguez-Aguayo C, Lopez-Berestein G, Liu J, Shmulevich I, Sood AK, Chen K, Zhang W.

Cancer Cell. 2013 Feb 11;23(2):186-99. doi: 10.1016/j.ccr.2012.12.020. Erratum in: Cancer Cell. 2013 May 13;23(5):705.

PMID:
23410973
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues.

Sfakianos GP, Iversen ES, Whitaker R, Akushevich L, Schildkraut JM, Murphy SK, Marks JR, Berchuck A.

Gynecol Oncol. 2013 Apr;129(1):159-64. doi: 10.1016/j.ygyno.2012.12.030. Epub 2012 Dec 26.

PMID:
23274563
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

Verhaak RG, Tamayo P, Yang JY, Hubbard D, Zhang H, Creighton CJ, Fereday S, Lawrence M, Carter SL, Mermel CH, Kostic AD, Etemadmoghadam D, Saksena G, Cibulskis K, Duraisamy S, Levanon K, Sougnez C, Tsherniak A, Gomez S, Onofrio R, Gabriel S, Chin L, Zhang N, Spellman PT, Zhang Y, Akbani R, Hoadley KA, Kahn A, Köbel M, Huntsman D, Soslow RA, Defazio A, Birrer MJ, Gray JW, Weinstein JN, Bowtell DD, Drapkin R, Mesirov JP, Getz G, Levine DA, Meyerson M; Cancer Genome Atlas Research Network.

J Clin Invest. 2013 Jan 2;123(1):517-25. doi: 10.1172/JCI65833. Epub 2012 Dec 21.

PMID:
23257362
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A network module-based method for identifying cancer prognostic signatures.

Wu G, Stein L.

Genome Biol. 2012 Dec 10;13(12):R112. doi: 10.1186/gb-2012-13-12-r112.

PMID:
23228031
[PubMed - in process]
Free PMC Article
20.

Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors.

Montero-Melendez T, Dalli J, Perretti M.

Cell Death Differ. 2013 Apr;20(4):567-75. doi: 10.1038/cdd.2012.154. Epub 2012 Dec 7.

PMID:
23222458
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk